2024-11-012025-10-312025-10-31false15243745JSD HEALTHCARE LTD2026-07-13falseiso4217:GBPxbrli:pure152437452024-10-31152437452025-10-31152437452024-11-012025-10-31152437452023-10-27152437452024-10-31152437452023-10-282024-10-3115243745bus:SmallEntities2024-11-012025-10-3115243745bus:AuditExempt-NoAccountantsReport2024-11-012025-10-3115243745bus:FullAccounts2024-11-012025-10-3115243745bus:PrivateLimitedCompanyLtd2024-11-012025-10-3115243745core:WithinOneYear2025-10-3115243745core:AfterOneYear2025-10-3115243745core:WithinOneYear2024-10-3115243745core:AfterOneYear2024-10-3115243745core:ShareCapital2025-10-3115243745core:SharePremium2025-10-3115243745core:RevaluationReserve2025-10-3115243745core:OtherReservesSubtotal2025-10-3115243745core:RetainedEarningsAccumulatedLosses2025-10-3115243745core:ShareCapital2024-10-3115243745core:SharePremium2024-10-3115243745core:RevaluationReserve2024-10-3115243745core:OtherReservesSubtotal2024-10-3115243745core:RetainedEarningsAccumulatedLosses2024-10-3115243745core:LandBuildings2025-10-3115243745core:PlantMachinery2025-10-3115243745core:Vehicles2025-10-3115243745core:FurnitureFittings2025-10-3115243745core:OfficeEquipment2025-10-3115243745core:NetGoodwill2025-10-3115243745core:IntangibleAssetsOtherThanGoodwill2025-10-3115243745core:ListedExchangeTraded2025-10-3115243745core:UnlistedNon-exchangeTraded2025-10-3115243745core:LandBuildings2024-10-3115243745core:PlantMachinery2024-10-3115243745core:Vehicles2024-10-3115243745core:FurnitureFittings2024-10-3115243745core:OfficeEquipment2024-10-3115243745core:NetGoodwill2024-10-3115243745core:IntangibleAssetsOtherThanGoodwill2024-10-3115243745core:ListedExchangeTraded2024-10-3115243745core:UnlistedNon-exchangeTraded2024-10-3115243745core:LandBuildings2024-11-012025-10-3115243745core:PlantMachinery2024-11-012025-10-3115243745core:Vehicles2024-11-012025-10-3115243745core:FurnitureFittings2024-11-012025-10-3115243745core:OfficeEquipment2024-11-012025-10-3115243745core:NetGoodwill2024-11-012025-10-3115243745core:IntangibleAssetsOtherThanGoodwill2024-11-012025-10-3115243745core:ListedExchangeTraded2024-11-012025-10-3115243745core:UnlistedNon-exchangeTraded2024-11-012025-10-3115243745core:MoreThanFiveYears2024-11-012025-10-3115243745core:Non-currentFinancialInstruments2025-10-3115243745core:Non-currentFinancialInstruments2024-10-3115243745dpl:CostSales2024-11-012025-10-3115243745dpl:DistributionCosts2024-11-012025-10-3115243745core:LandBuildings2024-11-012025-10-3115243745core:PlantMachinery2024-11-012025-10-3115243745core:Vehicles2024-11-012025-10-3115243745core:FurnitureFittings2024-11-012025-10-3115243745core:OfficeEquipment2024-11-012025-10-3115243745dpl:AdministrativeExpenses2024-11-012025-10-3115243745core:NetGoodwill2024-11-012025-10-3115243745core:IntangibleAssetsOtherThanGoodwill2024-11-012025-10-3115243745dpl:GroupUndertakings2024-11-012025-10-3115243745dpl:ParticipatingInterests2024-11-012025-10-3115243745dpl:GroupUndertakingscore:ListedExchangeTraded2024-11-012025-10-3115243745core:ListedExchangeTraded2024-11-012025-10-3115243745dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2024-11-012025-10-3115243745core:UnlistedNon-exchangeTraded2024-11-012025-10-3115243745dpl:CostSales2023-10-282024-10-3115243745dpl:DistributionCosts2023-10-282024-10-3115243745core:LandBuildings2023-10-282024-10-3115243745core:PlantMachinery2023-10-282024-10-3115243745core:Vehicles2023-10-282024-10-3115243745core:FurnitureFittings2023-10-282024-10-3115243745core:OfficeEquipment2023-10-282024-10-3115243745dpl:AdministrativeExpenses2023-10-282024-10-3115243745core:NetGoodwill2023-10-282024-10-3115243745core:IntangibleAssetsOtherThanGoodwill2023-10-282024-10-3115243745dpl:GroupUndertakings2023-10-282024-10-3115243745dpl:ParticipatingInterests2023-10-282024-10-3115243745dpl:GroupUndertakingscore:ListedExchangeTraded2023-10-282024-10-3115243745core:ListedExchangeTraded2023-10-282024-10-3115243745dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2023-10-282024-10-3115243745core:UnlistedNon-exchangeTraded2023-10-282024-10-3115243745core:NetGoodwill2025-10-3115243745core:IntangibleAssetsOtherThanGoodwill2025-10-3115243745core:LandBuildings2025-10-3115243745core:PlantMachinery2025-10-3115243745core:Vehicles2025-10-3115243745core:FurnitureFittings2025-10-3115243745core:OfficeEquipment2025-10-3115243745core:AfterOneYear2025-10-3115243745core:WithinOneYear2025-10-3115243745core:ListedExchangeTraded2025-10-3115243745core:UnlistedNon-exchangeTraded2025-10-3115243745core:ShareCapital2025-10-3115243745core:SharePremium2025-10-3115243745core:RevaluationReserve2025-10-3115243745core:OtherReservesSubtotal2025-10-3115243745core:RetainedEarningsAccumulatedLosses2025-10-3115243745core:NetGoodwill2024-10-3115243745core:IntangibleAssetsOtherThanGoodwill2024-10-3115243745core:LandBuildings2024-10-3115243745core:PlantMachinery2024-10-3115243745core:Vehicles2024-10-3115243745core:FurnitureFittings2024-10-3115243745core:OfficeEquipment2024-10-3115243745core:AfterOneYear2024-10-3115243745core:WithinOneYear2024-10-3115243745core:ListedExchangeTraded2024-10-3115243745core:UnlistedNon-exchangeTraded2024-10-3115243745core:ShareCapital2024-10-3115243745core:SharePremium2024-10-3115243745core:RevaluationReserve2024-10-3115243745core:OtherReservesSubtotal2024-10-3115243745core:RetainedEarningsAccumulatedLosses2024-10-3115243745core:NetGoodwill2023-10-2715243745core:IntangibleAssetsOtherThanGoodwill2023-10-2715243745core:LandBuildings2023-10-2715243745core:PlantMachinery2023-10-2715243745core:Vehicles2023-10-2715243745core:FurnitureFittings2023-10-2715243745core:OfficeEquipment2023-10-2715243745core:AfterOneYear2023-10-2715243745core:WithinOneYear2023-10-2715243745core:ListedExchangeTraded2023-10-2715243745core:UnlistedNon-exchangeTraded2023-10-2715243745core:ShareCapital2023-10-2715243745core:SharePremium2023-10-2715243745core:RevaluationReserve2023-10-2715243745core:OtherReservesSubtotal2023-10-2715243745core:RetainedEarningsAccumulatedLosses2023-10-2715243745core:AfterOneYear2024-11-012025-10-3115243745core:WithinOneYear2024-11-012025-10-3115243745core:Non-currentFinancialInstrumentscore:CostValuation2024-11-012025-10-3115243745core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-11-012025-10-3115243745core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-11-012025-10-3115243745core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-11-012025-10-3115243745core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-11-012025-10-3115243745core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-11-012025-10-3115243745core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-11-012025-10-3115243745core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-11-012025-10-3115243745core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-11-012025-10-3115243745core:Non-currentFinancialInstrumentscore:CostValuation2025-10-3115243745core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2025-10-3115243745core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2025-10-3115243745core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2025-10-3115243745core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2025-10-3115243745core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2025-10-3115243745core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2025-10-3115243745core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2025-10-3115243745core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2025-10-3115243745core:Non-currentFinancialInstrumentscore:CostValuation2024-10-3115243745core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-10-3115243745core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-10-3115243745core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-10-3115243745core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-10-3115243745core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-10-3115243745core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-10-3115243745core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-10-3115243745core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-10-3115243745bus:Director12024-11-012025-10-3115243745bus:Director22024-11-012025-10-31

JSD HEALTHCARE LTD

Registered Number
15243745
(England and Wales)

Unaudited Financial Statements for the Year ended
31 October 2025

JSD HEALTHCARE LTD
Company Information
for the year from 1 November 2024 to 31 October 2025

Directors

DOSANJH, Harjeevan Singh
PUREWAL, Gurminder Singh

Registered Address

112 Wolverhampton Road
Stafford
ST17 4AH

Registered Number

15243745 (England and Wales)
JSD HEALTHCARE LTD
Balance Sheet as at
31 October 2025

Notes

2025

2024

£

£

£

£

Fixed assets
Intangible assets3575,000575,000
Tangible assets433,3871,322
608,387576,322
Current assets
Stocks519,72519,725
Debtors6159,239114,439
Cash at bank and on hand113,50549,849
292,469184,013
Creditors amounts falling due within one year7(793,576)(751,867)
Net current assets (liabilities)(501,107)(567,854)
Total assets less current liabilities107,2808,468
Provisions for liabilities9(6,148)(55)
Net assets101,1328,413
Capital and reserves
Called up share capital100100
Profit and loss account101,0328,313
Shareholders' funds101,1328,413
The financial statements were approved and authorised for issue by the Board of Directors on 13 July 2026, and are signed on its behalf by:
DOSANJH, Harjeevan Singh
Director
Registered Company No. 15243745
JSD HEALTHCARE LTD
Notes to the Financial Statements
for the year ended 31 October 2025

1.Accounting policies
Basis of preparation
The accounts have been prepared under the historical cost convention and in accordance with FRS 102, the financial reporting standard applicable in the UK and Republic of Ireland (as applied to small entities by section 1A of the standard).
Turnover policy
Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and from the rendering of services.
Employee benefits
Short-term employee benefits are measured at the undiscounted amount expected to be paid in exchange for the employee's services to the company. Where employees have accrued short-term benefits which the entity has not paid by the balance sheet date, an accrual is recognised within creditors: amounts falling due within one year together with an associated expense in profit or loss. The liabilities are classified as current obligations in the statement of financial position because they are expected to be settled wholly within twelve months after the end of the period.
Current taxation
Current tax is recognised in profit or loss, except for taxes related to revaluations of land and buildings which are recognised in other comprehensive income. Current tax represents the amount of tax payable (receivable) in respect of taxable profit (loss) for the current, or past, reporting periods. Current tax is measured at the amount expected to be paid (recovered) using the tax rates and laws which have been enacted, or substantively enacted, by the balance sheet date. Where payments to HM Revenue and Customs exceed liabilities owed, an asset is recognised to the extent of the amount of tax recoverable.
Deferred tax
Deferred tax is recognised in respect of all timing differences between the recognition of income and expenses in the financial statements and their inclusion in tax assessments. Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference, except for revalued land and investment property where the tax rate that applies to the sale of the asset is used. Current and deferred tax assets and liabilities are not discounted.
Intangible assets
Intangible fixed assets are measured at cost.
Tangible fixed assets and depreciation
All fixed assets are initially recorded at cost. Property, plant and equipment is used in the company's principal activity for the production and supply of goods or for administrative purposes and is stated in the balance sheet under the historic cost model. This model requires the assets to be stated at cost less amounts in respect of depreciation and less any accumulated impairment losses. Depreciation is calculated so as to write off the cost of an asset, less its estimated residual value (which is the expected amount that would currently be obtained from disposal of an asset, after deducting the estimated costs of disposal, if the asset were already of the age and in the condition expected at the end of its useful life), over the useful economic life of the respective asset as follows: Leasehold land and buildings over the lease term Fixtures, fittings, tools and equipment 25% straight Line
Stocks and work in progress
Stock is valued at the lower of cost and estimated selling price less costs to complete and sell. The cost methodology employed by the entity is the first-in first-out method. Estimated selling price less costs to complete and sell are derived from the selling price which the goods would fetch in an open market transaction with established customers less the costs expected to be incurred to enable the sale to complete. Provision is made for slow-moving and obsolete items of stock. Such provisions are recognised in profit or loss. Work in progress is valued using the percentage of completion method and values are calculated using the lower of cost and estimated selling price less costs to complete and sell. When stocks are sold, the carrying amount of those stocks is recognised as an expense within cost of sales. This takes place in the same period that the associated revenue is recognised.
Trade and other debtors
Short term debtors are measured at transaction price (which is usually the invoice price), less any impairment losses for bad and doubtful debts. Loans and other financial assets are initially recognised at transaction price including any transaction costs and subsequently measured at amortised cost determined using the effective interest method, less any impairment losses for bad and doubtful debts.
Trade and other creditors
Short term creditors are measured at transaction price (which is usually the invoice price). Loans and other financial liabilities are initially recognised at transaction price net of any transaction costs and subsequently measured at amortised cost determined using the effective interest method.
2.Average number of employees

20252024
Average number of employees during the year77
3.Intangible assets

Other

Total

££
Cost or valuation
At 01 November 24575,000575,000
At 31 October 25575,000575,000
Net book value
At 31 October 25575,000575,000
At 31 October 24575,000575,000
4.Tangible fixed assets

Plant & machinery

Vehicles

Office Equipment

Total

££££
Cost or valuation
At 01 November 241,030-3891,419
Additions-31,7912,32234,113
At 31 October 251,03031,7912,71135,532
Depreciation and impairment
At 01 November 24--9797
Charge for year-1,8072412,048
At 31 October 25-1,8073382,145
Net book value
At 31 October 251,03029,9842,37333,387
At 31 October 241,030-2921,322
5.Stocks

2025

2024

££
Other stocks19,72519,725
Total19,72519,725
6.Debtors: amounts due within one year

2025

2024

££
Trade debtors / trade receivables155,764113,056
Prepayments and accrued income3,4751,383
Total159,239114,439
7.Creditors: amounts due within one year

2025

2024

££
Trade creditors / trade payables129,50798,207
Bank borrowings and overdrafts626,511650,443
Taxation and social security19,3271,894
Accrued liabilities and deferred income18,2311,323
Total793,576751,867
8.Creditors: amounts due after one year
9.Provisions for liabilities

2025

2024

££
Net deferred tax liability (asset)6,14855
Total6,14855